Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial

被引:5
|
作者
Schiappacassa, Alessandra [1 ]
Maranhao, Priscila A. [1 ]
Coelho de Souza, Maria das Gracas [1 ,2 ]
Panazzolo, Diogo G. [1 ]
Nogueira Neto, Jose Firmino [3 ]
Bouskela, Eliete [2 ]
Kraemer-Aguiar, Luiz Guilherme [2 ,4 ]
机构
[1] Univ Estado Rio De Janeiro, Fac Med Sci, Postgrad Program Clin & Expt Physiopathol FISCLIN, BR-20550013 Rio De Janeiro, RJ, Brazil
[2] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, BR-20550013 Rio De Janeiro, RJ, Brazil
[3] Univ Estado Rio De Janeiro, Policlin Piquet Carneiro, Lipids Lab Lablip, BR-20550003 Rio De Janeiro, RJ, Brazil
[4] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Obes Unit,Policlin Piquet Carneiro, BR-20550030 Rio De Janeiro, RJ, Brazil
关键词
diabetes; microcirculation; metformin; vildagliptin; postprandial; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; GLUCOSE; CHOLESTEROL; INSULIN; ASSOCIATION; DYSFUNCTION; PLASMA; GLP-1;
D O I
10.3390/jcm9103228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 diabetes mellitus and obesity are both related to endothelial dysfunction. Postprandial lipemia is a cardiovascular risk. Notably, it is known that a high-fat diet may elicit microvascular dysfunction, even in healthy subjects. Since anti-diabetic drugs have different mechanisms of action and also distinct vascular benefits, we aimed to compare the results of two anti-diabetic drugs after the intake of a lipid-rich meal on microcirculation in patients with type 2 diabetes and obesity. In parallel, we also investigated the metabolic profile, oxidative stress, inflammation, plasma viscosity, and some gastrointestinal peptides. Subjects/Methods: We included 38 drug-naive patients, all women aged between 19 and 50 years, with BMI >= 30 kg/m(2). We performed endothelial measurements and collected samples before (fasting) and after the intake of a lipid-rich meal at 30, 60, 120, and 180 min. Patients were randomized to metformin or vildagliptin, given orally just before the meal. Endothelial function was assessed by videocapillaroscopy and laser-Doppler flowmetry to investigate microvascular reactivity. Besides, we also investigated plasma viscosity, inflammatory and oxidative stress biomarkers, gastrointestinal peptides, and metabolic profile in all time points. Results: No differences at baseline were noted between groups. Vildagliptin increased glucagon-like peptide-1 compared to metformin. Paired comparisons showed that, during the postprandial period, vildagliptin significantly changed levels of insulin and glucagon-like peptide-1, and also the dipeptidyl peptidase-4 activity, while metformin had effects on plasma glucose solely. Metformin use during the test meal promoted an increase in functional capillary density, while vildagliptin kept non-nutritive microvascular blood flow and vasomotion unchanged. Conclusions: After the intake of a lipid-rich meal, the use of vildagliptin preserved postprandial non-nutritive microflow and vasomotion, while metformin increased capillary recruitment, suggesting protective and different mechanisms of action on microcirculation.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [21] Postprandial metabolic effects of fructose and glucose in type 1 diabetes patients: a pilot randomized crossover clinical trial
    Souto, Debora Lopes
    Lima, Erika dos Santos
    Dantas, Joana Rodrigues
    Zajdenverg, Lenita
    Rodacki, Melanie
    Rosado, Eliane Lopes
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2019, 63 (04): : 376 - 384
  • [22] Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes-a randomized controlled trial
    Esposito, K.
    Maiorino, M. I.
    Di Palo, C.
    Gicchino, M.
    Petrizzo, M.
    Bellastella, G.
    Saccomanno, F.
    Giugliano, D.
    DIABETES OBESITY & METABOLISM, 2011, 13 (05) : 439 - 445
  • [23] Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan
    Malha, Line P.
    Taan, Ghazi
    Zantout, Mira S.
    Azar, Sami T.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (01) : 3 - 9
  • [24] Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: A randomized clinical trial
    Esteghamati, Alireza
    Eskandari, Delaram
    Mirmiranpour, Hossein
    Noshad, Sina
    Mousavizadeh, Mostafa
    Hedayati, Mehdi
    Nakhjavani, Manouchehr
    CLINICAL NUTRITION, 2013, 32 (02) : 179 - 185
  • [25] Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
    Hermansen, K.
    Baekdal, T. A.
    During, M.
    Pietraszek, A.
    Mortensen, L. S.
    Jorgensen, H.
    Flint, A.
    DIABETES OBESITY & METABOLISM, 2013, 15 (11) : 1040 - 1048
  • [26] Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes
    N. Matikainen
    S. Mänttäri
    A. Schweizer
    A. Ulvestad
    D. Mills
    B. E. Dunning
    J. E. Foley
    M.-R. Taskinen
    Diabetologia, 2006, 49 : 2049 - 2057
  • [27] Gender-dependent Effects of Metformin on Vaspin and Adiponectin in Type 2 Diabetes Patients: A Randomized Clinical Trial
    Esteghamati, A.
    Mousavizadeh, M.
    Noshad, S.
    Zandieh, A.
    Zarei, H.
    Nakhjavani, M.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (04) : 319 - 325
  • [28] Pistachio Nut Effects on the Blood Lipid Profile in Patients With Type II Diabetes Mellitus: A Single-Blind Randomized Crossover Controlled Clinical Trial
    Khorramirad, Ashraf
    Heidari, Saeide
    Parham, Mahmoud
    Jang, Shahram Arsang
    Hozoori, Mohammad
    IRANIAN HEART JOURNAL, 2021, 22 (03): : 23 - 32
  • [29] A Randomized Trial of the Effects of Insulin and Metformin on Myocardial Stress in Patients With Type II Diabetes Mellitus
    Srivastava, Pratyaksh K.
    Pradhan, Aruna D.
    Cook, Nancy R.
    Ridker, Paul M.
    Everett, Brendan M.
    CIRCULATION, 2017, 136
  • [30] EFFECT OF MEAL TIME ON POSTPRANDIAL GLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND OBESITY NOT RECEIVING INSULIN
    Misnikova, Inna, V
    Zoloeva, Dzerassa E.
    Glazkov, Alexey A.
    DIABETES MELLITUS, 2023, 26 (05): : 455 - 463